Insider · CIK 0001478007

Klein Peter S

Reports to the SEC for 6 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001478007

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-03	DNLIDenali Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+19.2K sh	—	—	19,226
2026-06-03	DNLIDenali Therapeutics Inc.A Award	Director	AAward	+6,408 sh	—	—	33,941
2025-06-03	DNLIDenali Therapeutics Inc.A Award	Director	AAward	+6,037 sh	—	—	27,533
2025-06-03	DNLIDenali Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+18.1K sh	—	—	18,111
2025-04-08	Accolade, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−35K sh	—	—	0
2025-04-08	Accolade, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−28.3K sh	$7.03	−$199K	0
2025-04-08	Accolade, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2025-04-08	Accolade, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,600 sh	—	—	0
2025-03-13	FFIVF5, INC. · Restricted Stock UnitA Award	Director	AAward	+934 sh	—	—	934
2025-03-12	FFIVF5, INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−1,309 sh	—	—	0
2025-03-12	FFIVF5, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,309 sh	—	—	13,333
2024-09-05	FFIVF5, INC.G Gift	Director	GGift	−1,000 sh	—	—	12,024
2024-08-06	Accolade, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−9,196 sh	—	—	0
2024-08-06	Accolade, Inc.Restricted Stock UnitsA Award	Director	AAward	+35K sh	—	—	35,021
2024-08-06	Accolade, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+9,196 sh	—	—	28,329
2024-05-31	DNLIDenali Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+17.9K sh	—	—	17,901
2024-05-31	DNLIDenali Therapeutics Inc.A Award	Director	AAward	+5,967 sh	—	—	21,496
2024-03-14	FFIVF5, INC. · Restricted Stock UnitA Award	Director	AAward	+1,309 sh	—	—	1,309
2024-03-13	FFIVF5, INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−1,770 sh	—	—	0
2024-03-13	FFIVF5, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,770 sh	—	—	13,024
2023-09-05	FFIVF5, INC.G Gift	Director	GGift	−1,200 sh	—	—	11,254
2023-08-18	Accolade, Inc.Restricted Stock UnitsA Award	Director	AAward	+9,196 sh	—	—	9,196
2023-07-25	Accolade, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−14.1K sh	—	—	0
2023-07-25	Accolade, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+14.1K sh	—	—	19,133
2023-06-14	PDYNPalladyne AI Corp.A Award	Director	AAward	+195K sh	—	—	265,066
2023-06-01	DNLIDenali Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.6K sh	—	—	12,649
2023-06-01	DNLIDenali Therapeutics Inc.A Award	Director	AAward	+4,216 sh	—	—	15,529
2023-03-09	FFIVF5, INC. · Restricted Stock UnitA Award	Director	AAward	+1,770 sh	—	—	1,770
2023-03-08	FFIVF5, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,272 sh	—	—	12,454
2023-03-08	FFIVF5, INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−1,272 sh	—	—	0
2023-02-28	Accolade, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+604 sh	—	—	5,073
2023-02-28	Accolade, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−604 sh	—	—	0
2022-11-30	Accolade, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−603 sh	—	—	604
2022-11-30	Accolade, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+603 sh	—	—	4,469
2022-08-31	Accolade, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+604 sh	—	—	3,866
2022-08-31	Accolade, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−604 sh	—	—	1,207
2022-07-26	Accolade, Inc.Restricted Stock UnitsA Award	Director	AAward	+14.1K sh	—	—	14,060
2022-07-21	Accolade, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,659 sh	$9.67	+$25.7K	3,262
2022-07-21	Accolade, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,659 sh	—	—	0
2022-06-29	PDYNPalladyne AI Corp.A Award	Director	AAward	+57.7K sh	—	—	70,007
2022-06-02	DNLIDenali Therapeutics Inc.A Award	Director	AAward	+5,986 sh	—	—	11,313
2022-06-02	DNLIDenali Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+18K sh	—	—	17,959
2022-05-31	Accolade, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−603 sh	—	—	1,811
2022-05-31	Accolade, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+603 sh	—	—	603
2022-03-10	FFIVF5, INC. · Restricted Stock UnitA Award	Director	AAward	+1,272 sh	—	—	1,272
2022-03-09	FFIVF5, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,282 sh	—	—	11,182
2022-03-09	FFIVF5, INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−1,282 sh	—	—	0
2022-03-01	Accolade, Inc.Restricted Stock UnitsA Award	Director	AAward	+2,414 sh	—	—	2,414
2021-12-09	PDYNPalladyne AI Corp.A Award	Director	AAward	+12.3K sh	—	—	12,315
2021-07-22	Accolade, Inc.Restricted Stock UnitsA Award	Director	AAward	+2,659 sh	—	—	2,659

Recent filings

Accepted (ET)
Jun 54
Klein Peter S0001478007-26-000002
SEC(opens sec.gov)
Jun 54
Klein Peter S0001714899-25-000140
SEC(opens sec.gov)
Apr 84
Klein Peter S0001415889-25-010345
SEC(opens sec.gov)
Mar 144
Klein Peter S0001048695-25-000055
SEC(opens sec.gov)
Sep 64
Klein Peter S0001048695-24-000140
SEC(opens sec.gov)
Aug 84
Klein Peter S0001127602-24-021877
SEC(opens sec.gov)
Aug 84
Klein Peter S0001127602-24-021859
SEC(opens sec.gov)
Jun 44
Klein Peter S0001714899-24-000133
SEC(opens sec.gov)
Mar 154
Klein Peter S0001048695-24-000033
SEC(opens sec.gov)

Companies

Address

C/O DENALI THERAPEUTICS INC. 161 OYSTER POINT BLVD.

SOUTH SAN FRANCISCO, CA, 94080